Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019

107
Published Date: 2014-08-26

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Microfluidics is an enabling technology for integration, industrialization, miniaturization and parallelization of tests in diagnostics, drug development and biological research. Microfluidic devices have several applications in the field of medicine, cell biology research and protein crystallization. It also has many applications in other areas such as drug screening, sugar testers, chemical micro reactor, microprocessor cooling and micro fuel cells.


North America dominates the global microfluidic devices market. Rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Similarly, in Europe, the microfluidic device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems.


Rising demand for point of care testing, miniaturization of chip, and increasing demand for microfluidic devices in genomics and proteomics are the key growth drivers for the microfluidic device market. New trends in healthcare, such as healthcare at home supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Miniaturization reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. On the other hand, strict regulatory requirements are a major concern for the industry. Safety, performance and consistent quality of medical devices are a necessity for public health. Thus, it leads to strict and complex regulations and standards for global affiliation of medical devices.


Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices. Change in material mix would provide opportunity for new market entrants, which would further drive the growth of the microfluidic device market. Research and commercialization emphasis has shifted to micro devices made entirely from polymeric material. However, major challenges faced by the microfluidic devices industry are the geometrical and surface chemistry issues during manufacturing of a device. In complex microfluidic devices, geometrical and surface chemistry issues combine and lead to design and manufacturing difficulties


This report provides an in-depth analysis of estimation of the microfluidic device market for the period 2013-2019, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The microfluidic device market is categorized on the basis of material used for manufacturing microfluidic devices, industry, application and geography. Based on industry, the microfluidic device market comprises in-vitro diagnostics, pharmaceuticals and medical devices. The application market comprises point of care testing, analytical devices, pharmaceutical and life science research, clinical and veterinary diagnostics, drug delivery and environment and industry.


In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). Some of the major players in the microfluidic device market are Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Inc, Fluidigm Corporation and Johnson & Johnson. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Table of Content


Chapter 1 Preface 11

1.1 Report Description 11

1.2 Research Methodology 12

1.3 Assumptions 12


Chapter 2 Market Synopsis 13


Chapter 3 Porter Five Forces Analysis 15

3.1 Bargaining power of suppliers 15

3.2 Bargaining power of buyers 16

3.3 Threat of new entrants 16

3.4 Threat of substitutes 16

3.5 Intensity of rivalry 16


Chapter 4 Industry Overview 17

4.1 Market Definition 17

4.2 Market Drivers 19

      4.2.1 Rising demand for point of care testing 19

      4.2.2 Miniaturization of chip, reduces the cost of testing 20

      4.2.3 Increasing demand of microfluidic devices in genomics and proteomics 21

      4.2.4 Change in material mix provides new opportunities for new players in the market 21

4.3 Impact Analysis of Market Drivers 22

4.4 Market Restraints 22

      4.4.1 Strict regulatory requirements 23

      4.4.2 Geometrical and surface chemistry issues are a challenge for microfluidics 24

4.5 Impact Analysis of Market Restraints 24

4.6 Market Trends 25

      4.6.1 Rising number of collaborations and partnerships 25

      4.6.2 Rising number of product innovations 25


Chapter 5 Global Market Size and Forecast 27


Chapter 6 Market Size and Forecast by Material 34

6.1 Glass 34

6.2 Polymer 36

6.3 Silicon 38


Chapter 7 Market Size and Forecast by Industry 41

7.1 In-vitro diagnostics 41

7.2 Pharmaceutical 43

7.3 Medical Devices 49


Chapter 8 Market Size and Forecast by Industry 53

8.1 Point of care testing 53

8.2 Pharmaceutical and life science research 55

8.3 Drug Delivery 58

8.4 Analytical devices 60

8.5 Clinical and veterinary diagnostics 63

8.6 Environment and Industrial 65


Chapter 9 Market Size and Forecast by Geography 69

9.1 North America 69

9.2 Europe 71

9.3 Asia 74

9.4 Rest of the World 76


Chapter 10 Competitive Scenario 78

10.1 Competitive Benchmarking 78


Chapter 11 Company Profiles 80

11.1 Roche Diagnostics 80

      11.1.1 Company Overview 80

      11.1.2 Products and Services 80

      11.1.3 Financial Performance 81

      11.1.4 Recent Developments 81

11.2 Abbott Laboratories 83

      11.2.1 Company Overview 83

      11.2.2 Products and Services 83

      11.2.3 Financial Performance 84

      11.2.4 Recent Developments 85

11.3 Siemens Healthcare 86

      11.3.1 Company Overview 86

      11.3.2 Products and Services 86

      11.3.3 Financial Performance 87

      11.3.4 Recent Developments 87

11.4 Agilent Technologies, Inc 88

      11.4.1 Company Overview 88

      11.4.2 Products and Services 88

      11.4.3 Financial Performance 89

      11.4.4 Recent Developments 89

11.5 Fluidigm Corporation 90

      11.5.1 Company Overview 90

      11.5.2 Products and Services 90

      11.5.3 Financial Performance 90

      11.5.4 Recent Developments 91

11.6 Bio-Rad Laboratories, Inc. 93

      11.6.1 Company Overview 93

      11.6.2 Products and Services 93

      11.6.3 Financial Performance 94

      11.6.4 Recent Developments 94

11.7 Cepheid 95

      11.7.1 Company Overview 95

      11.7.2 Products and Services 95

      11.7.3 Financial Performance 95

      11.7.4 Recent Developments 96

11.8 RainDance Technologies, Inc. 98

      11.8.1 Company Overview 98

      11.8.2 Products and Services 98

      11.8.3 Financial Performance 98

      11.8.4 Recent Developments 99

11.9 Dolomite Centre 100

      11.9.1 Company Overview 100

      11.9.2 Products and Services 100

      11.9.3 Financial Performance 100

      11.9.4 Recent Developments 100

11.10 Micronit Microfluidics 102

      11.10.1 Company Overview 102

      11.10.2 Products and Services 102

      11.10.3 Financial Performance 102

      11.10.4 Recent Developments 102

11.11 Johnson & Johnson 103

      11.11.1 Company Overview 103

      11.11.2 Products and Services 103

      11.11.3 Financial Performance 103

      11.11.4 Recent Developments 104

11.12 Becton, Dickinson and Company 105

      11.12.1 Company Overview 105

      11.12.2 Products and Services 105

      11.12.3 Financial Performance 106

      11.12.4 Recent Developments 106


List of Tables


TABLE 1 Market Snapshot: microfluidic device market (2013 & 2019) 13

TABLE 2 Drivers for microfluidic devices market: Impact analysis 22

TABLE 3 Restraints for microfluidic devices market: Impact analysis 24

TABLE 4 Major collaborations and partnerships by microfluidic device companies (2011-2013) 25

TABLE 5 Some of the products launched by various companies 26

TABLE 6 Global microfluidic devices market size, by region 2009-2012 (USD million) 27

TABLE 7 Global microfluidic devices market size, by region 2013-2019 (USD million) 28

TABLE 8 Global microfluidic devices market size, by material 2009-2012 (USD million) 29

TABLE 9 Global microfluidic devices market size, by material 2013-2019 (USD million) 30

TABLE 10 Global microfluidic devices market size, by industry 2009-2012 (USD million) 31

TABLE 11 Global microfluidic devices market size, by industry 2013-2019 (USD million) 31

TABLE 12 Global microfluidic devices market size, by application 2009-2012 (USD million) 32

TABLE 13 Global microfluidic devices market size, by application 2013-2019 (USD million) 33

TABLE 14 Glass microfluidic devices market size, by region 2009-2012 (USD million) 35

TABLE 15 Glass microfluidic devices market size, by region 2013-2019 (USD million) 35

TABLE 16 Polymer microfluidic devices market size, by region 2009-2012 (USD million) 37

TABLE 17 Polymer microfluidic devices market size, by region 2013-2019 (USD million) 38

TABLE 18 Silicon microfluidic devices market size, by region 2009-2012 (USD million) 39

TABLE 19 Silicon microfluidic devices market size, by region 2013-2019 (USD million) 40

TABLE 20 In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million) 42

TABLE 21 In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million) 42

TABLE 22 Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million) 44

TABLE 23 Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million) 45

TABLE 24 Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million) 46

TABLE 25 Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million) 47

TABLE 26 Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million) 48

TABLE 27 Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million) 48

TABLE 28 Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million) 50

TABLE 29 Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million) 50

TABLE 30 Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million) 51

TABLE 31 Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million) 52

TABLE 32 Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million) 54

TABLE 33 Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million) 55

TABLE 34 Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million) 57

TABLE 35 Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million) 57

TABLE 36 Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million) 59

TABLE 37 Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million) 60

TABLE 38 Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million) 62

TABLE 39 Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million) 62

TABLE 40 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million) 64

TABLE 41 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million) 65

TABLE 42 Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million) 67

TABLE 43 Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million) 67

TABLE 44 The North American microfluidic devices market size, by country 2009-2012 (USD million) 70

TABLE 45 The North American microfluidic devices market size, by country 2013-2019 (USD million) 71

TABLE 46 The European microfluidic devices market size, by country 2009-2012 (USD million) 72

TABLE 47 The European microfluidic devices market size, by country 2013-2019 (USD million) 73

TABLE 48 The Asian microfluidic devices market size, by country 2009-2012 (USD million) 75

TABLE 49 The Asian microfluidic devices market size, by country 2013-2019 (USD million) 76

TABLE 50 Roche Diagnostics major product categories 80

TABLE 51 Abbott Laboratories major product categories 83

TABLE 52 Siemens Healthcare major product categories 86

TABLE 53 Agilent Technologies major product categories 88

TABLE 54 Major Fluidigm Corporation products and its application 90

TABLE 55 Major Bio-Rad Laboratories products and categories 93

TABLE 56 Major Cepheid products and categories 95

TABLE 57 Major RainDance Technologies products and its applications 98

TABLE 58 Major Dolomite Centre products and categories 100

TABLE 59 Major Micronit Microfluidics products and categories 102

TABLE 60 Major Johnson & Johnson segments and products 103

TABLE 61 Major Becton, Dickinson and Company segments and products 105


List of Figures 


FIG. 1 Microfluidic Device Market: Porters Five Force Analysis 15

FIG. 2 Applications of Microfluidics 18

FIG. 3 Functions of Microfluidics 19

FIG. 4 Aging population in major regions (% 2000-2050) 20

FIG. 5 Global microfluidic device market, by region 2013 (% share) 27

FIG. 6 Global microfluidic device market, by material 2013 (% share) 29

FIG. 7 Global microfluidic device market, by industry 2013 (% share) 30

FIG. 8 Global microfluidic device market, by application 2013 (% share) 32

FIG. 9 Glass microfluidic device market, by region 2013 (% share) 34

FIG. 10 Polymer microfluidic device market, by region 2013 (% share) 37

FIG. 11 Silicon microfluidic device market, by region 2013 (% share) 39

FIG. 12 In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share) 41

FIG. 13 Pharmaceutical industry in microfluidic device market, by region 2013 (% share) 44

FIG. 14 Pharmaceutical industry in microfluidic device market, by product 2013 (% share) 46

FIG. 15 Chips for lab analytics in microfluidic device market, by product 2013 (% share) 47

FIG. 16 Medical device industry in microfluidic device market, by region 2013 (% share) 49

FIG. 17 Medical devices industry in microfluidic device market, by product 2013 (% share) 51

FIG. 18 Microfluidic device material used in point of care testing in 2010 (% share) 53

FIG. 19 Point of care testing in microfluidic device market, by region 2013 (% share) 54

FIG. 20 Microfluidic device material in pharmaceutical and life science research in 2010 (% share) 56

FIG. 21 Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share) 56

FIG. 22 Microfluidic device material in drug delivery in 2010 (% share) 58

FIG. 23 Drug delivery in microfluidic device market, by region 2013 (% share) 59

FIG. 24 Microfluidic device material in analytical devices in 2010 (% share) 61

FIG. 25 Analytical Devices in microfluidic device market, by region 2013 (% share) 61

FIG. 26 Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share) 63

FIG. 27 Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share) 64

FIG. 28 Microfluidic device material in environment and industrial application in 2010 (% share) 66

FIG. 29 Environment and industrial application in microfluidic device market, by region 2013 (% share) 66

FIG. 30 The North American microfluidic device market, by country 2013 (% share) 70

FIG. 31 The European microfluidic device market, by country 2013 (% share) 72

FIG. 32 The Asian microfluidic device market, by country 2013 (% share) 75

FIG. 33 Competitive landscape of global microfluidic device market 78

FIG. 34 Roche sales and net income 2011-2013 (USD Million) 81

FIG. 35 Abbott Laboratories net sales and net earnings 2011-2013 (USD Million) 84

FIG. 36 Siemens revenue and net income 2011-2013 (USD Million) 87

FIG. 37 Agilent Technologies net revenue and net income 2011-2013 (USD Million) 89

FIG. 38 Fluidigm Corporation total revenue and net income 2011-2013 (USD Million) 91

FIG. 39 Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million) 94

FIG. 40 Cepheid sales and net income 2011-2013 (USD Million) 96

FIG. 41 Johnson & Johnson sales and net earnings 2011-2013 (USD Million) 104

FIG. 42 Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million) 106

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. It has several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments. Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as healthcare at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting integration of laboratory protocols into miniaturized devices called lab on chip. Miniaturization reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. Microfluidic devices offer various advantages for genomics including improved test speed, reduced reagent consumption and efficacy. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.


North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.


North America was valued at USD 644.5 million in 2013 and is expected to reach USD 2,095.5 million in 2019, growing at a CAGR of 21.7% from 2013 to 2019.


Point of care testing in the global microfluidic device market was valued at USD 316.7 million in 2013 and is expected to reach USD 1,412.1 million in 2019, growing at a CAGR of 28.3% from 2013 to 2019.